Back to Search Start Over

Outcomes of transcatheter mitral valve replacement for degenerated bioprostheses, failed annuloplasty rings, and mitral annular calcification

Authors :
Vinayak Bapat
Paul Sorajja
Azeem Latib
John G. Webb
Christian Frerker
Thomas Pilgrim
Harindra C. Wijeysundera
David Hildick-Smith
James E. Davies
Sabine Bleiziffer
Tarun Chakravarty
Brian Whisenant
Ermela Yzeiraj
Christian Jung
Sung Han Yoon
Daisuke Sugiyama
Gilbert H.L. Tang
Florian Deuschl
Simon Redwood
Miriam Silaschi
Buntaro Fujita
Raj Makkar
Rajiv Rampat
Tobias Schmidt
S. Chiu Wong
Thomas Modine
Ulrich Schaefer
Flavien Vincent
Guilherme F. Attizzani
Saibal Kar
Victoria Delgado
Niklas Schofer
Pedro Felipe Gomes Nicz
Alexander Lauten
Francesco Maisano
Jeroen J. Bax
Eric Van Belle
Eric J Bansal
Colin MacLeod Barker
Albert M. Kasel
Antonio H. Frangieh
Luis Nombela-Franco
Sameer A. Hirji
Hiroki Niikura
Masahiko Asami
Shingo Kuwata
Jean Bernard Masson
Daniel J. Blackman
Joachim Schofer
Stephan Ensminger
Lena Eschenbach
Dale Murdoch
Christoph J Jensen
Tsuyoshi Kaneko
Martin Arnold
Enrique Gutiérrez-Ibañes
Horst Sievert
Axel Unbehaun
Fabio Sandoli de Brito
Hendrik Treede
Won-Keun Kim
Marco Ancona
Richard W. Smalling
Bernard Prendergast
Abhijeet Dhoble
Joerg Kempfert
Source :
European Heart Journal, 40(5), 441-451. OXFORD UNIV PRESS
Publication Year :
2019

Abstract

Aims We sought to evaluate the outcomes of transcatheter mitral valve replacement (TMVR) for patients with degenerated bioprostheses [valve-in-valve (ViV)], failed annuloplasty rings [valve-in-ring (ViR)], and severe mitral annular calcification [valve-in-mitral annular calcification (ViMAC)]. Methods and results From the TMVR multicentre registry, procedural and clinical outcomes of ViV, ViR, and ViMAC were compared according to Mitral Valve Academic Research Consortium (MVARC) criteria. A total of 521 patients with mean Society of Thoracic Surgeons score of 9.0 ± 7.0% underwent TMVR (322 patients with ViV, 141 with ViR, and 58 with ViMAC). Trans-septal access and the Sapien valves were used in 39.5% and 90.0%, respectively. Overall technical success was excellent at 87.1%. However, left ventricular outflow tract obstruction occurred more frequently after ViMAC compared with ViR and ViV (39.7% vs. 5.0% vs. 2.2%; P

Details

Language :
English
Database :
OpenAIRE
Journal :
European Heart Journal, 40(5), 441-451. OXFORD UNIV PRESS
Accession number :
edsair.doi.dedup.....a2b7050750108ad18dcbab683c2f256a